Zając Piotr, Plewka Michał, Rogowski Waldemar, Kasprzak Jarosław D
Department of Cardiology, Medical University of Łódź, Poland.
Kardiochir Torakochirurgia Pol. 2014 Dec;11(4):437-40. doi: 10.5114/kitp.2014.47348. Epub 2014 Nov 30.
Aortic stenosis (AS) is the third most common cardiovascular disease. Aortic valve replacement (AVR) is the only effective method of treatment in most AS patients. In some patients, AS leads to poststenotic dilatation of the ascending aorta - most commonly, this occurs in patients with concurrent aortic regurgitation or bicuspid aortic valve (BAV) and in patients after aortic valve replacement. Cardiac surgeons face the dilemma whether to perform concurrent replacement of the dilated ascending aorta in patients qualified for AVR, as it is associated with an increased risk of perioperative complications and mortality. We report a case of a patient with an ascending aortic aneurysm, who had been implanted with an aortic mechanical valve (Lillehei-Kaster 16 ECC) 37 years earlier.
主动脉瓣狭窄(AS)是第三常见的心血管疾病。主动脉瓣置换术(AVR)是大多数AS患者唯一有效的治疗方法。在一些患者中,AS会导致升主动脉狭窄后扩张——最常见于合并主动脉瓣反流或二叶式主动脉瓣(BAV)的患者以及主动脉瓣置换术后的患者。心脏外科医生面临着一个两难的抉择,即对于有资格接受AVR的患者,是否同时进行扩张升主动脉的置换,因为这与围手术期并发症和死亡率增加相关。我们报告一例升主动脉瘤患者,该患者37年前植入了一枚主动脉机械瓣膜(Lillehei-Kaster 16 ECC)。